These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38615521)
1. Mechanisms of therapeutic change after psychedelic treatment in OCD. Maloney G; Ching T; Kichuk SA; Pittenger C; Kelmendi B Psychiatry Res; 2024 Jun; 336():115907. PubMed ID: 38615521 [TBL] [Abstract][Full Text] [Related]
2. Psilocybin for the Treatment of Obsessive-Compulsive Disorders. Ehrmann K; Allen JJB; Moreno FA Curr Top Behav Neurosci; 2022; 56():247-259. PubMed ID: 34784024 [TBL] [Abstract][Full Text] [Related]
14. An Investigation of Cognitive and Affective Changes During Group Imagery Rescripting for Social Anxiety Disorder. McCarthy A; Bank SR; Campbell BNC; Summers M; Burgess M; McEvoy P Behav Ther; 2022 Sep; 53(5):1050-1061. PubMed ID: 35987535 [TBL] [Abstract][Full Text] [Related]
15. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history. Pearson C; Siegel J; Gold JA J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586 [TBL] [Abstract][Full Text] [Related]
16. Should cognitive restructuring precede imagery rescripting? An experimental pilot study. Voncken MJ; Janssen I; Keijsers GPJ; Dibbets P J Behav Ther Exp Psychiatry; 2023 Mar; 78():101800. PubMed ID: 36435542 [TBL] [Abstract][Full Text] [Related]
17. Effects of imagery rescripting on consolidated memories of an aversive film. Siegesleitner M; Strohm M; Wittekind CE; Ehring T; Kunze AE J Behav Ther Exp Psychiatry; 2019 Mar; 62():22-29. PubMed ID: 30176538 [TBL] [Abstract][Full Text] [Related]
18. Psilocybin-assisted therapy for depression: How do we advance the field? Meikle SE; Liknaitzky P; Rossell SL; Ross M; Strauss N; Thomas N; Murray G; Williams M; Castle DJ Aust N Z J Psychiatry; 2020 Mar; 54(3):225-231. PubMed ID: 31752499 [TBL] [Abstract][Full Text] [Related]
19. DARK Classics in Chemical Neuroscience: Psilocybin. Geiger HA; Wurst MG; Daniels RN ACS Chem Neurosci; 2018 Oct; 9(10):2438-2447. PubMed ID: 29956917 [TBL] [Abstract][Full Text] [Related]
20. Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Majić T; Schmidt TT; Gallinat J J Psychopharmacol; 2015 Mar; 29(3):241-53. PubMed ID: 25670401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]